COH34 analog 1

CAS No. 314248-24-3

COH34 analog 1( —— )

Catalog No. M32852 CAS No. 314248-24-3

COH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 44 In Stock
25MG 91 In Stock
50MG 145 In Stock
100MG 233 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    COH34 analog 1
  • Note
    Research use only, not for human use.
  • Brief Description
    COH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.
  • Description
    COH34 analog 1, a metabolite, is an oxidized analog of COH34. COH34 is a potent poly(ADP-ribose) glycohydrolase (PARG) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    314248-24-3
  • Formula Weight
    325.38
  • Molecular Formula
    C18H15NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (307.33 mM; Ultrasonic )
  • SMILES
    Cc1ccc(cc1)S(=O)(=O)\N=C\c1c(O)ccc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen SH, et al. Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies. Sci Adv. 2019 Apr 10;5(4):eaav4340.?
molnova catalog
related products
  • Albanol B

    Albanol B is an arylbenzofuran derivative which can be isolated from mulberries. Albanol B exhibits anti-Alzheimer's disease, anti-bacterial and antioxidant activities. Albanol B inhibits cancer cells proliferation, down-regulates CDK1 expression. Albanol B also induces cell cycle arrest at G2/M and apoptosis. And Albanol B induces mitochondrial ROS production and increases the phosphorylation levels of AKT and ERK1/2.

  • AF-1

    AF1 Neuropeptide, known as a sequenced bioactive neuropeptide, was seperated from the nematode Ascaris suum.

  • LOC14

    LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).